302-17-0 Usage
Chemical Description
Chloral hydrate and chloral alcoholate are derivatives of chloral used in the synthesis of DDT.
Description
Chloral hydrate is one of the oldest sedatives used for dental sedation. It was first synthesized in 1832 by Justus von Liebig and was the first synthetic central nervous system (CNS) depressant. It was used to treat delirium tremens, insomnia, and anxiety, although it is considered an unapproved drug by the US Food and Drug Administration. Initially considered to be a safer alternative to opium, it was noted to produce rapid unconsciousness when combined with ethanol. Physical dependence can occur with chronic use.Chloral hydrate is classified as a sedative-hypnotic and is known to induce sleep in children. It has been very popular in pediatric dentistry since the mid-1950s. Chloral hydrate is rapidly absorbed following oral administration and is converted through its first pass in the liver to trichloroethanol，its active form. Trichloroethanol is conjugated in the liver and excreted in the urine. Like other agents that are metabolized in the liver, chloral hydrate may interact with other drugs, herbs, or foods resulting in clinically significant alterations of the agents (e.g.,warfarin).
Chemical Properties
Chloral is a combustible, oily liquid with a
pungent irritating odor.
Uses
Different sources of media describe the Uses of 302-17-0 differently. You can refer to the following data:
1. Trichloroacetaldehyde Hydrate is a useful chemical reagent used as a sedative/hypnotic agent for the short-term treatment of insomnia. First developed in 1832, chloral hydrate is the oldest sleep medication still in use today. This medication is also used to calm you just before surgery or other procedures. It works by affecting certain parts of the brain to cause calmness.
Studies have shown that when used in pediatric sedation side effects such as hallucination, excessive sleep and seizures were observed. Drowsiness and trouble waking up in the morning, nausea, vomiting, stomach pain, diarrhea, and headache may occur. Stomach problems can be reduced by taking chloral hydrate with a full glass of water. It is sometimes administered to patients being treated with cyclophosphamide and it is known to inhibit some aldehyde dehydrogenases.
Besides, Chloral hydrate is a starting point for the synthesis of other organic compounds. It is the starting material for the production of chloral, which is produced by the distillation of a mixture of chloral hydrate and sulfuric acid, which serves as the desiccant.
2. Chloral hydrate is used as an intermediate in the production of insecticides, herbicides and hypnotic drugs. It has also been widely used as a sedative or hypnotic drug in humans at oral doses of up to about 750-1000 mg/day. Chloral hydrate is used as a sedative hypnotic, more commonly in pediatrics. With the advent of newer sedative hypnotics, its use has significantly decreased. It is also a drug of abuse, particularly in combination with ethanol to produce an amnestic effect in an individual who ingests it unknowingly.
Definition
ChEBI: An organochlorine compound that is the hydrate of trichloroacetaldehyde.
Biological Functions
Chloral hydrate (Noctec, Somnos) was developed in
the late 1800s and is still used as a sedative–hypnotic
agent. It is a hydrated aldehyde with a disagreeable
smell and taste that is rapidly reduced in vivo to
trichloroethanol, which is considered to be the active
metabolite. It produces a high incidence of gastric irritation
and allergic responses, occasionally causes cardiac
arrhythmias, and is unreliable in patients with liver
damage.
General Description
Different sources of media describe the General Description of 302-17-0 differently. You can refer to the following data:
1. Chloral hydrate, trichloroacetaldehydemonohydrate, CCl3CH(OH)2 (Noctec), is analdehyde hydrate stable enough to be isolated. The relativestability of this gem-diol is largely a result of an unfavorabledipole–dipole repulsion between the trichloromethyl carbonand the carbonyl carbon present in the parent carbonylcompound.Chloral hydrate is unstable in alkaline solutions, undergoingthe last step of the haloform reaction to yield chloroformand formate ion. In hydroalcoholic solutions, it formsthe hemiacetal with ethanol. Whether or not this compoundis the basis for the notorious and potentially lethal effect of the combination of ethanol and chloral hydrate (the “MickeyFinn”) is controversial. Synergism between two differentCNS depressants also could be involved. Additionally,ethanol, by increasing the concentration of nicotinamideadenine dinucleotide (NADH), enhances the reduction ofchloral to the more active metabolite trichloroethanol, andchloral can inhibit the metabolism of alcohol because it inhibitsalcohol dehydrogenase. Chloral hydrate is a weak acidbecause its CCl3 group is very strong electron withdrawing.A 10% aqueous solution of chloral hydrate has pH 3.5 to4.4, which makes it irritating to mucous membranes in thestomach. As a result, GI upset commonly occurs for thedrug if undiluted or taken on an empty stomach. Chloral hydrateas a capsule, syrup, or suppository is currently available.
2. Transparent colorless crystals or white crystalline solid. Aromatic penetrating slightly acrid odor and a slightly bitter caustic taste. Alcoholic solution (1 in 20) does not at once redden moistened blue litmus paper.
Air & Water Reactions
Water soluble.
Reactivity Profile
Chloral hydrate is incompatible with alkalis, alkaline earth metals, alkali carbonates and soluble barbiturates. Chloral hydrate is decomposed by sodium hydroxide. Chloral hydrate reduces ammoniacal silver nitrate. Chloral hydrate liquefies when triturated with an equal quantity of menthol, camphor or thymol. . Reaction of Chloral hydrate with hydroxylamine produces toxic hydrogen cyanide gas, Org. Synth., 1941, Vol. 1, 377.
Hazard
Overdose toxic, hypnotic drug, dangerous
to eyes. Probable carcinogen.
Fire Hazard
Flash point data for Chloral hydrate are not available; however, Chloral hydrate is probably combustible.
Flammability and Explosibility
Nonflammable
Biochem/physiol Actions
Chloral hydrate is a sedative/hypnotic.
Clinical Use
Although it is suggested that chloral hydrate per semay act as a hypnotic,chloral hydrate is very quickly convertedto trichloroethanol, which is generally assumed toaccount for almost all of the hypnotic effect. Thetrichloroethanol is metabolized by oxidation to chloral andthen to the inactive metabolite, trichloracetic acid, which is also extensively metabolized to acylglucuronidesvia conjugation with glucuronic acid. It appears tohave potent barbiturate-like binding to GABAAreceptors.Although an old drug, it still finds use as a sedative in nonoperatingroom procedures for the pediatric patient.
Safety Profile
A human poison by
ingestion and possibly other routes. Poison
experimentally by ingestion, intravenous,
and rectal routes. Moderately toxic by
subcutaneous, parenteral, and intraperitoneal
routes, Experimental reproductive effects.
Human systemic effects by ingestion:
general anesthetic, cardiac arrhythmias,
blood pressure depression, eye effects,
coma, pulse rate increase, arrhythmias.
Human mutation data reported.
Questionable carcinogen with experimental
carcinogenic and tumorigenic data by skin
contact. A sedative, anesthetic, and narcotic.
Combustible when exposed to heat or
flame. When heated to decomposition it
emits toxic fumes of Cl-.
Synthesis
Chloral hydrate, 2,2,2-trichloro-1,1-ethandiol (4.3.1), is synthesized
either by chlorination of ethanol or chlorination of acetaldehyde and the subsequent addition of water molecules to the resulting trichloroacetic aldehyde [31].
Potential Exposure
Chloral is used as an intermediate
in the manufacture of such pesticides as DDT, methoxychlor, DDVP, naled, trichlorfon, and TCA. Chloral is
also used in the production of chloral hydrate; used as
a therapeutic agent with hypnotic, sedative, and narcotic
effects; used in a time prior to the introduction of
barbiturates
Drug interactions
Potentially hazardous interactions with other drugs
Anticoagulants: may transiently enhance effect of
coumarins.
Antipsychotics: enhanced sedative effects.
Antivirals: concentration possibly increased by
ritonavir.
Carcinogenicity
Chloral hydrate has not been adequately tested for teratogenicity,
reproductive effects, or chronic toxicity. Similarly, no
histological evaluations have been conducted.
Environmental Fate
Chloral hydrate is a CNS depressant, but its mechanism of
action is not well known. Coingestion with ethanol produces
enhanced effects by several mechanisms. First, ethanol
competes for alcohol and aldehyde dehydrogenase, which then
prolongs the half-life of ethanol. The metabolism of ethanol
generates the reduced form of NADH, which is a cofactor for
the metabolism of chloral hydrate to its active metabolite
trichloroethanol. Finally, ethanol inhibits the conjugation of
trichloroethanol to its inactive form urochloralic acid. This
results in enhanced CNS depression.
Metabolism
Chloral hydrate is rapidly metabolised to trichloroethanol
(the active metabolite) and trichloroacetic acid in the
erythrocytes, liver, and other tissues. It is excreted partly
in the urine as trichloroethanol and its glucuronide
(urochloralic acid) and as trichloroacetic acid. Some is
also excreted in the bile.
Shipping
UN2811 Toxic solids, organic, n.o.s., Hazard
Class: 6.1; Labels: 6.1-Poisonous materials, Technical
Name Required.
Toxicity evaluation
Chloral hydrate has been detected at 5 mg l-1 in the US drinking
water supply. Although chloral hydrate does not exist naturally,
it can be produced as a by-product of chlorination of water at
water treatment facilities, specifically in exposed water with
high amounts of humic and fulvic substances.
Incompatibilities
Chloral hydrate reacts with strong bases
forming chloroform. Contact with acids, or exposure to
light may cause polymerization. Reacts with water, forming
chloral hydrate. Reacts with oxidizers, with a risk of fire or
explosions.
Waste Disposal
Incineration after mixing with
another combustible fuel; care must be taken to assure complete combustion to prevent phosgene formation; an acid
scrubber is necessary to remove the halo acids produced.
Check Digit Verification of cas no
The CAS Registry Mumber 302-17-0 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,0 and 2 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 302-17:
(5*3)+(4*0)+(3*2)+(2*1)+(1*7)=30
30 % 10 = 0
So 302-17-0 is a valid CAS Registry Number.
InChI:InChI=1/C2HCl3O.H2O/c3-2(4,5)1-6;/h1H;1H2
302-17-0Relevant articles and documents
Kinetics and mechanistic investigation into the degradation of naproxen by a UV/chlorine process
Gao, Yu-Qiong,Gao, Nai-Yun,Chu, Wen-Hai,Yang, Qin-Lin,Yin, Da-Qiang
, p. 33627 - 33634 (2017)
In this study, UV irradiation combined with chlorine (UV/chlorine) was used to degrade naproxen (NPX), a typical non-steroidal anti-inflammatory drug (NSAID) widely used for the treatment of symptoms associated with inflammation, in water. Compared with UV irradiation alone and direct chlorination, the UV/chlorine process shows a synergistic effect on NPX degradation. The effects of different factors, including the chlorine dose, solution pH, and the presence of Cl-, HCO3- or humic acid (HA), on NPX degradation in the UV/chlorine process were investigated. The results indicated that the degradation of NPX followed pseudo-first-order kinetics in all cases, and the rate constant increased as the chlorine dose increased and decreased as the pH increased. The effects of the water matrix on UV/chlorine treatment were species-dependent. The NPX degradation rate was inhibited by the presence of HCO3- and HA but significantly improved by Cl-. LC/MS/MS analysis indicated that NPX decomposition in the UV/chlorine process was associated with decarboxylation, demethylation and hydroxylation. These results indicate that the UV/chlorine process is a promising technology for the treatment of water polluted by emerging contaminants, such as NPX. However, UV/chlorine can notably enhance the formation of disinfection by-products compared to direct chlorination, which should be carefully considered when integrating this process into drinking water treatment schemes.
Thermally induced oxidative decarboxylation of copper complexes of amino acids and formation of strecker aldehyde
Nashalian, Ossanna,Yaylayan, Varoujan A.
, p. 8518 - 8523 (2015/04/22)
In the Maillard reaction, independent degradations of amino acids play an important role in the generation of amino-acid-specific products, such as Strecker aldehydes or their Schiff bases. Such oxidative decarboxylation reactions are expected to be enhan
Metabolism of trichloroethylene and chloral hydrate by the Japanese medaka (Oryzias latipes) in vitro
Lipscomb, John C.,Confer, Patricia D.,Miller, Michael R.,Stamm, Steven C.,Snawder, John E.,Bandiera, Stelvio M.
, p. 325 - 332 (2007/10/03)
Trichloroethylene (TRI), a common groundwater contaminant, is readily metabolized by mammals to produce chloral hydrate (CH), trichloroacetic acid (TCA), and trichloroethanol (TCOH). Cytochrome P450 (CYP) and other enzymes are responsible for formation of these metabolites, which are implicated in TRI's toxicity and carcinogenicity. To establish the validity of the Japanese medaka (Oryzias latipes) as an alternate test species for TRI, we examined the metabolism of TRI and CH, as well as CYP expression, in medaka liver preparations. Trichloroethylene was incubated with medaka microsomal protein, and metabolites were extracted and analyzed using gas chromatography. Microsome-mediated metabolism of TRI was observed, and a K(m) value for TRI oxidation of 540 μM and a V(max) value of 213 pmol/min·mg-1 protein were obtained. Conversion of TRI to CH, TCA, and TCOH was found with medaka hepatic subcellular fractions. In addition, a sex difference in hepatic microsomal TRI metabolism, specific CYP content, and ethoxyresorufin O- deethylase activity was noted. The lower specific activity of preparations from the livers of female medaka is compensated for by increased total protein in the larger liver mass of the female. Immunochemical analysis showed that CYP1A was readily detectable in medaka liver, but CYP2E1 was present at very low levels. These data suggest that TRI metabolism in medaka liver preparations mimics that observed in mammalian systems and supports their use as an alternative test species in the evaluation of the toxicity of TRI.
